Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system.

Manuel WallbachEllen BornDeborah KämpferStephan LüdersGerhard A MüllerRolf WachterMichael J Koziolek

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2019)

BAT reduced office BP and improved relevant parameters of ABP, which is associated with a high cardiovascular risk, in patients with resistant HTN, whereas, after adjustment for baseline BP, BP reduction was not different in patients with CH compared with patients with ISH. However, randomized controlled trials are needed to confirm the effects of BAT on 24-h ABP.

Keyphrases

randomized controlled trial
electronic health record
big data
clinical trial
machine learning
mesenchymal stem cells
artificial intelligence
ionic liquid